83 related articles for article (PubMed ID: 2730687)
21. Stabilization of 8S progesterone receptor from human prostate in the presence of molybdate ion.
Bevins CL; Bashirelahi N
Cancer Res; 1980 Jul; 40(7):2234-9. PubMed ID: 7190061
[TBL] [Abstract][Full Text] [Related]
22. Effects of progestins on the progesterone receptor in guinea pig uterus.
Saffran J; Loeser BK; Faber LE
Adv Exp Med Biol; 1979; 117():223-39. PubMed ID: 474278
[TBL] [Abstract][Full Text] [Related]
23. Mammalian progesterone receptor shows differential sensitivity to sulfhydryl group modifying agents when bound to agonist and antagonist ligands.
Moudgil VK; Anter MJ; Hurd C
J Biol Chem; 1989 Feb; 264(4):2203-11. PubMed ID: 2914901
[TBL] [Abstract][Full Text] [Related]
24. Human progesterone receptor A and B isoforms in CHO cells. II. Comparison of binding, transactivation and ED50 values of several synthetic (anti)progestagens in vitro in CHO and MCF-7 cells and in vivo in rabbits and rats.
Schoonen WG; Dijkema R; de Ries RJ; Wagenaars JL; Joosten JW; de Gooyer ME; Deckers GH; Kloosterboer HJ
J Steroid Biochem Mol Biol; 1998 Feb; 64(3-4):157-70. PubMed ID: 9605410
[TBL] [Abstract][Full Text] [Related]
25. Human progesterone receptor A and B isoforms in CHO cells. I. Stable transfection of receptor and receptor-responsive reporter genes: transcription modulation by (anti)progestagens.
Dijkema R; Schoonen WG; Teuwen R; van der Struik E; de Ries RJ; van der Kar BA; Olijve W
J Steroid Biochem Mol Biol; 1998 Feb; 64(3-4):147-56. PubMed ID: 9605409
[TBL] [Abstract][Full Text] [Related]
26. Classical membrane progesterone receptors in murine mammary carcinomas: agonistic effects of progestins and RU-486 mediating rapid non-genomic effects.
Bottino MC; Cerliani JP; Rojas P; Giulianelli S; Soldati R; Mondillo C; Gorostiaga MA; Pignataro OP; Calvo JC; Gutkind JS; Panomwat Amornphimoltham ; Molinolo AA; Lüthy IA; Lanari C
Breast Cancer Res Treat; 2011 Apr; 126(3):621-36. PubMed ID: 20535544
[TBL] [Abstract][Full Text] [Related]
27. Non-genomic effects of progestins--inhibition of cell growth and increased intracellular levels of cyclic nucleotides.
Sager G; Ørbo A; Jaeger R; Engström C
J Steroid Biochem Mol Biol; 2003 Jan; 84(1):1-8. PubMed ID: 12648518
[TBL] [Abstract][Full Text] [Related]
28. Cytoplasmic progestin receptors in myomal and myometrial tissues. Concentrations and hormonal dependency.
Büchi KA; Keller PJ
Acta Obstet Gynecol Scand; 1983; 62(5):487-92. PubMed ID: 6666562
[TBL] [Abstract][Full Text] [Related]
29. Specific interactions of progestins and anti-progestins with progesterone antibodies, plasma binding proteins and the human recombinant receptor.
Mais DE; Hayes JS; Heap RB; Wang MW
J Steroid Biochem Mol Biol; 1995 Jul; 54(1-2):63-9. PubMed ID: 7632616
[TBL] [Abstract][Full Text] [Related]
30. Hormone receptors of the baboon cardiovascular system. Biochemical characterization of aortic and myocardial cytoplasmic progesterone receptors.
Lin AL; McGill HC; Shain SA
Circ Res; 1982 May; 50(5):610-6. PubMed ID: 7200404
[TBL] [Abstract][Full Text] [Related]
31. Binding of progestins to the glucocorticoid receptor. Correlation to their glucocorticoid-like effects on in vitro functions of human mononuclear leukocytes.
Kontula K; Paavonen T; Luukkainen T; Andersson LC
Biochem Pharmacol; 1983 May; 32(9):1511-8. PubMed ID: 6222739
[TBL] [Abstract][Full Text] [Related]
32. Classification and pharmacology of progestins.
Schindler AE; Campagnoli C; Druckmann R; Huber J; Pasqualini JR; Schweppe KW; Thijssen JH
Maturitas; 2003 Dec; 46 Suppl 1():S7-S16. PubMed ID: 14670641
[TBL] [Abstract][Full Text] [Related]
33. Interaction of antiprogestins with progesterone receptors in rat uterus.
Vij U; Murugesan K; Kalita JC; Farooq A
J Steroid Biochem; 1989 Feb; 32(2):279-82. PubMed ID: 2921869
[TBL] [Abstract][Full Text] [Related]
34. The progesterone receptor. Biological effects of progestins and antiprogestins.
Savouret JF; Chauchereau A; Misrahi M; Lescop P; Mantel A; Bailly A; Milgrom E
Hum Reprod; 1994 Jun; 9 Suppl 1():7-11. PubMed ID: 7962473
[TBL] [Abstract][Full Text] [Related]
35. Synthesis of potential antiprogestins II.
Beyer B; Terenius L; Counsell RE
Steroids; 1980 May; 35(5):481-8. PubMed ID: 7394854
[TBL] [Abstract][Full Text] [Related]
36. Cytoplasmic-nuclear trafficking of progesterone receptor. In vivo study of the mechanism of action of antiprogestins.
Guiochon-Mantel A; Delabre K; Lescop P; Perrot-Applanat M; Milgrom E
Biochem Pharmacol; 1994 Jan; 47(1):21-4. PubMed ID: 8311841
[TBL] [Abstract][Full Text] [Related]
37. [Radioreceptor assay for determination of the anti-progestogen, RU-486 and its active metabolites in the blood].
Földesi I; Falkay G; Kovács L
Acta Pharm Hung; 1992 Nov; 62(6):271-7. PubMed ID: 1488912
[TBL] [Abstract][Full Text] [Related]
38. Effects of antiprogestins on the rate of proliferation of breast cancer cells.
Iwasaki K; Underwood B; Herman M; Dinda S; Kodali S; Kloosterboer HJ; Hurd C; Moudgil VK
Mol Cell Biochem; 1999 Aug; 198(1-2):141-9. PubMed ID: 10497889
[TBL] [Abstract][Full Text] [Related]
39. In vivo evidence against the existence of antiprogestins disrupting receptor binding to DNA.
Delabre K; Guiochon-Mantel A; Milgrom E
Proc Natl Acad Sci U S A; 1993 May; 90(10):4421-5. PubMed ID: 8506282
[TBL] [Abstract][Full Text] [Related]
40. Progestin 16 alpha, 17 alpha-dioxolane ketals as molecular probes for the progesterone receptor: synthesis, binding affinity, and photochemical evaluation.
Kym PR; Carlson KE; Katzenellenbogen JA
J Med Chem; 1993 Apr; 36(9):1111-9. PubMed ID: 8387596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
